Sisram Medical Ltd (HKG:1696)
Hong Kong · Delayed Price · Currency is HKD 5.76
-0.36 (-5.88%)
Aug 1, 2025, 4:08 PM HKT
Revance Therapeutics Market Cap
Sisram Medical has a market cap or net worth of 2.70 billion as of August 1, 2025. Its market cap has increased by 74.55% in one year.
Market Cap
2.70B
Enterprise Value
2.62B
Revenue
2.71B
Ranking
n/a
PE Ratio
13.83
Stock Price
$5.76
Market Cap Chart
Since September 19, 2017, Sisram Medical's market cap has decreased from 3.57B to 2.70B, a decrease of -24.49%. That is a compound annual growth rate of -3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.70B | 52.38% |
| Dec 31, 2024 | 1.77B | -27.98% |
| Dec 29, 2023 | 2.46B | -41.03% |
| Dec 30, 2022 | 4.17B | -5.78% |
| Dec 31, 2021 | 4.42B | 202.27% |
| Dec 31, 2020 | 1.46B | -19.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 284.77B |
| Hansoh Pharmaceutical Group Company | 216.43B |
| Innovent Biologics | 168.29B |
| JD Health International | 159.85B |
| Akeso | 137.15B |
| WuXi Biologics | 136.72B |
| Sino Biopharmaceutical | 135.03B |
| CSPC Pharmaceutical Group | 112.84B |